Hematology-Oncology Clinics of North America

Papers
(The median citation count of Hematology-Oncology Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Prognostic and Predictive Implications of Cytogenetics and Genomics103
Autoimmune Hemolytic Anemia: An Old Disease with New Twists67
Managing First-Line Metastatic Renal Cell Carcinoma58
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia48
Conflict and Access to Health Care48
Insights into Renal Cell Carcinoma with Novel Imaging Approaches34
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia32
Cancer of the Larynx and Hypopharynx32
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver32
Treatment of High-Risk Gestational Trophoblastic Neoplasia30
Contents26
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis26
Contributors24
Benefits and Harms of Interception and Early Detection of Cancer23
Hematology/Oncology Clinics of North America23
Current Therapy and Emerging Intravesical Agents to Treat Non–Muscle Invasive Bladder Cancer22
Contributors22
Copyright22
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer21
Disparities in Breast Cancer Outcomes and How to Resolve Them20
Updates in the Management of Warm Autoimmune Hemolytic Anemia20
Advances in Gastric Cancer Surgical Management20
The Evolving Landscape of Drug Therapies for Sickle Cell Disease19
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes18
Advances in Immunotherapy in Esophagogastric Cancer17
Factor XIII Deficiency17
Future Directions for Gestational Trophoblastic Disease17
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas16
Forthcoming Issues16
Potential Relevance of B-cell Maturation Pathways in Defining the Cell(s) of Origin for Chronic Lymphocytic Leukemia15
Advances in Surgical Techniques for Lung Cancer14
Emerging Therapies in β-Thalassemia14
Inherited Platelet Disorders14
Foreword13
Contents13
Advances in Systemic Therapy in Pancreatic Cancer13
The Need for Translational Epidemiology in Beta Thalassemia Syndromes13
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma13
Adult Evans' Syndrome13
Liposarcoma12
Genomic Alterations in Langerhans Cell Histiocytosis12
The Ongoing Unmet Needs in Chronic Lymphocytic Leukemia12
Histiocytic Disorders in Pediatric and Adult Patients12
Clinical Characteristics and Treatment of Histiocytic Disorders in Children12
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors11
Genes as Medicine11
Copyright11
Hereditary Renal Cell Carcinoma Syndromes11
Red Cell Antigens and Antibodies11
Forthcoming Issues11
Clinical Vignettes Part I11
Malignancies of the Upper Gastrointestinal Tract10
Evaluation and Management of Bing–Neel Syndrome10
New Developments in Myeloma10
Skin Cancer Precursors10
Genomics of Resistance to Targeted Therapies10
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities9
Patient-Reported Outcomes in Radiation Oncology9
Gestational Trophoblastic Neoplasia9
Evolution of Gene Therapy, Historical Perspective9
High-Risk Non-Melanoma Skin Cancers9
Contents9
Copyright9
Bispecific Antibodies in the Treatment of Multiple Myeloma8
Contents8
Heavy Ion Particle Therapy in Modern Day Radiation Oncology8
Local Control in Soft Tissue Sarcomas8
Copyright8
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy8
Forthcoming Issues8
Advances in the Surgical Management of Esophageal Cancer8
Disparities and Inequities Among Patients with Central Nervous System Tumor7
Contents7
Breast Cancer and Lifestyle Factors7
Melanoma Brain Metastasis7
Breast Cancer in India7
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer7
Radiation-Induced Tissue Regeneration7
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms7
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma7
Chronic Lymphocytic Leukemia6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?6
FLASH Radiotherapy6
Clinical Complications and Their Management6
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases6
Future Directions in Bladder Cancer Treatment and Research—The Patient Advocates’ Perspective6
Education and Training Models for Remote Learning6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies6
Copyright6
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers6
Treatment of Chronic Lymphocytic Leukemia After Discontinuation of Bruton’s Tyrosine Kinase Inhibitors6
Copyright5
Early Detection of Precursor Diseases of Multiple Myeloma5
Disorders of Fibrinogen and Fibrinolysis5
Targeted Therapy Innovations for Melanoma5
Contents5
Current Perioperative Therapy for Muscle Invasive Bladder Cancer5
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma5
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy5
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma5
Hemophilia A/B5
Impact of Clonal Heterogeneity in Multiple Myeloma5
Ductal Carcinoma In Situ5
Immunotherapy-associated Autoimmune Hemolytic Anemia4
Immune-Pathogenesis of Myeloma4
Merkel Cell Carcinoma4
Contributors4
Renal Cell Cancer4
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)4
Complications of Autoimmune Hemolytic Anemia4
Management of Waldenström Macroglobulinemia in Limited-Resource Settings4
Approach to High-Risk Multiple Myeloma4
Pathogenic Mechanisms in Thalassemia II4
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia4
Local Therapies in Advanced Colorectal Cancer4
Pathogenic Mechanisms in Thalassemia I4
Role of Radiation in Treatment of Renal Cell Carcinoma4
Forthcoming Issues4
Current Therapy for Metastatic Urothelial Carcinoma4
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia4
Genetics and Genomics of Gestational Trophoblastic Disease4
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis4
Contributors4
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing4
Contents4
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors4
Regulatory Aspects of Gene Therapy4
Remembering the Contributions of Professor David J. Weatherall4
Contents3
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity3
Debate3
Contributors3
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia3
Hereditary Colorectal Cancer3
Contents3
Contributors3
Breast Cancer Pathology in the Era of Genomics3
Escalation, De-escalation, Adaptation, Speciation, Customization: The New Approaches to Breast Cancer3
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?3
Preface3
Cutaneous T-cell Lymphoma3
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia3
Smoldering Multiple Myeloma3
Functional Radiosurgery in the Management of Cancer Pain3
Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals3
Copyright3
Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH)3
Innovation and Emerging Technologies in Radiation Oncology3
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma3
Biology and Treatment of Meningiomas3
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer3
Cancer of the Paranasal Sinuses3
Waldenström Macroglobulinemia3
Gastrointestinal Cancer Precursor Conditions and Their Detection3
Contents3
Contributors3
Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia3
Role of Ovarian Suppression in Early Premenopausal Breast Cancer3
Preface3
First-Line Treatment of Driver-Negative Non–Small Cell Lung Cancer2
Molecular Biology of Bladder Cancer2
Macrophage Activation Syndrome2
Impact of Social Media on Oncology Care2
The Emerging Potential of Lead-212 Theranostics2
Immunotherapy2
Contributors2
Contents2
Emerging Role of Blood-based Biomarkers in Sarcomas2
Chronic Lymphocytic Leukemia: So Much Progress, Still Challenges Ahead2
Surgical Management of Gestational Trophoblastic Neoplasia2
Contents2
Neurofibromatoses2
Diagnosis and Staging of Bladder Cancer2
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer2
Robotic and Endoscopic Approaches to Head and Neck Surgery2
Evolving Concepts in the Management of Desmoid Tumors2
Forthcoming Issues2
Contributors2
Factor XI Deficiency2
Artificial Intelligence, Machine Learning and Big Data in Radiation Oncology2
Patient, Caregiver, and Provider Well-Being in Oncology2
Evidence-Based Guidance for Breast Cancer Survivorship2
Forthcoming Issues2
Contributors2
Contents2
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer2
Copyright2
New Therapies on the Horizon2
Role of Surgery in Metastatic Renal Cell Carcinoma2
Contemporary and Emerging Approaches to Bladder-Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer2
Hematopoietic Stem Cell Transplantation in Thalassemia2
Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer2
Forthcoming Issues2
Microbiome and Immunotherapy for Melanoma2
Gene Therapy for Inborn Errors of Immunity2
Forthcoming Issues2
Copyright2
Advances and Opportunities in the Management of Lung Cancer2
Novel Targeted Therapies for Renal Cell Carcinoma2
Contributors2
Surgical Management of Neuroendocrine Tumor Liver Metastases2
Surgical Management of Genitourinary Cancer Liver Metastases2
Colorectal Cancer in Younger Adults2
Forthcoming Issues2
Immunotherapy for Head and Neck Cancer2
The Epidemiology of Bladder Cancer2
Contributors1
Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond1
Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?1
Radiologic Evaluation of the Head and Neck Cancer Patient1
Cervical Cancer1
Surgical Management of the Axilla for Breast Cancer1
Surgical Management of Colorectal Cancer Liver Metastases1
Radiotherapy for Pancreatic Adenocarcinoma1
The Gut Microbiome in Colorectal Cancer1
Bladder Cancer1
Chimeric Antigen Receptor T-cell Therapy1
Forthcoming Issues1
Cereblon-Targeting Ligase Degraders in Myeloma1
Quality of Life in Sickle Cell Disease1
Contents1
Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy1
Gene-Based Therapies for Pediatric Blood Diseases1
Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care1
The Role of the Pathologist in Renal Cell Carcinoma Management1
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease1
Copyright1
Smart Solutions to Address the Global Gap in Radiation Oncology Through Trainee Engagement and Partnerships with Industry1
Lip and Oral Cavity Squamous Cell Carcinoma1
Colorectal Cancer: Advancing Science, Improving Access, and Refining Therapy1
Lung Cancer1
Role of Consolidation and Maintenance1
Contributors1
Gene Therapy for Hemoglobinopathies1
Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases1
Nonoperative Management for Rectal Cancer1
Pathology of Gestational Trophoblastic Disease (GTD)1
Fighting Cancer in Ukraine at Times of War1
Locally Advanced Lung Cancer1
Hemophilia B (Factor IX Deficiency)1
Novel Immune Therapies for Renal Cell Carcinoma1
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma1
Preclinical Models for Bladder Cancer Research1
Sickle Cell Disease: New Approaches for an Old Disease1
Copyright1
Leptomeningeal Disease1
0.26693987846375